Higuchi Ryota, Ota Takehiro, Yazawa Takehisa, Kajiyama Hideki, Araida Tatsuo, Furukawa Toru, Yoshikawa Tatsuya, Takasaki Ken, Yamamoto Masakazu
Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.
Ebara Hospital, Tokyo, Japan.
Surg Today. 2016 Jan;46(1):74-83. doi: 10.1007/s00595-015-1119-1. Epub 2015 Feb 5.
This study aimed to examine the changes in procedures for hilar cholangiocarcinoma (HC) surgery and patient survival following HC surgery over a 40-year period.
Between 1974 and 2014, 239 consecutive patients underwent surgery for HC. The changes in perioperative therapy and short- and long-term surgical outcomes were evaluated.
The rates of major hepatectomy (in particular, right hepatectomy) and R0 resection significantly increased. Blood loss, transfusion rate, morbidity, and surgical mortality all significantly decreased. The 5-year disease-specific survival was 9.29 % (n = 38) in 1974-1988, 41.1 % (n = 88) in 1989-2003 and 55.6 % (n = 57) in 2004-2008 (p = 0.0001: 1974-1988 vs 1989-2003, p < 0.0001:1974-1988 vs 2004-2008, p = 0.076: 1989-2003 vs 2004-2008). According to a multivariate analysis, Bismuth classification IV (HR vs I, 2.86), period 1989-2003 (HR vs 1974-1988, 0.31), 2004-2008 (HR vs 1974-1988, 0.26), and R1 or R2 resection (HR vs R0, 2.22) were independent prognostic factors.
The surgical outcomes for HC over the 40-year period clearly improved as a result of aggressive surgery and progress in surgical techniques, perioperative management, and diagnostic tools.
本研究旨在探讨40年间肝门部胆管癌(HC)手术方式的变化以及HC手术后患者的生存情况。
1974年至2014年期间,239例连续性患者接受了HC手术。评估围手术期治疗及短期和长期手术结局的变化。
扩大肝切除术(尤其是右肝切除术)和R0切除率显著增加。失血量、输血率、发病率和手术死亡率均显著降低。1974 - 1988年5年疾病特异性生存率为9.29%(n = 38),1989 - 2003年为41.1%(n = 88),2004 - 2008年为55.6%(n = 57)(p = 0.0001:1974 - 1988年与1989 - 2003年相比,p < 0.0001:1974 - 1988年与2004 - 2008年相比,p = 0.076:1989 - 2003年与2004 - 2008年相比)。多因素分析显示,Bismuth分型IV(与I相比,HR为2.86)、1989 - 2003年(与1974 - 1988年相比,HR为0.31)、2004 - 2008年(与1974 - 1988年相比,HR为0.26)以及R1或R2切除(与R0相比,HR为2.22)是独立的预后因素。
由于积极的手术方式以及手术技术、围手术期管理和诊断工具的进步,40年间HC的手术结局明显改善。